At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
POM PomDoctor
Market Closed 04-02 16:00:00 EDT
0.2447
-0.0036
-1.45%
盘后0.2447
+0.00000.00%
16:04 EDT
High0.2600Low0.2401Vol91.26K
Open0.2450D1 Closing0.2483Amplitude8.01%
Mkt Cap28.98MTradable Cap1.22MTotal Shares118.44M
T/O22.41KT/O Rate1.83%Tradable Shares5.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Pomdoctor files Form 3 as director Jing Yuanyuan Crystal reports no beneficial ownership
Reuters  ·  04-03 18:46
Pomdoctor files Form 3 as director Jing Yuanyuan Crystal reports no beneficial ownership
Pomdoctor files Form 3 as CFO Li Xu reports beneficial ownership
Reuters  ·  04-03 18:44
Pomdoctor files Form 3 as CFO Li Xu reports beneficial ownership
Pomdoctor files Form 3 for VP, director Luo Guoji, reporting no securities owned
Reuters  ·  04-01
Pomdoctor files Form 3 for VP, director Luo Guoji, reporting no securities owned
Polyplastics' DURACON(R) POM Adopted for Ground-breaking Crawler Transport System
prnewswire  ·  03-25
Polyplastics' DURACON(R) POM Adopted for Ground-breaking Crawler Transport System
Pomdoctor Ltd. Plans R&D and Deployment of AI-Powered Medical-Grade Wearables to Build a Closed-Loop, Full-Cycle Chronic Disease Management Ecosystem
Reuters  ·  03-13
Pomdoctor Ltd. Plans R&D and Deployment of AI-Powered Medical-Grade Wearables to Build a Closed-Loop, Full-Cycle Chronic Disease Management Ecosystem
Pomdoctor Limited Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management
THOMSON REUTERS  ·  03-13
Pomdoctor Limited Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management
Class action lawsuit targets PomDoctor over alleged securities fraud between Oct. 9 and Dec. 11, 2025
Reuters  ·  03-13
Class action lawsuit targets PomDoctor over alleged securities fraud between Oct. 9 and Dec. 11, 2025
ADRs Advance; PomDoctor Ltd. Climbs 74%
Dow Jones  ·  03-10
ADRs Advance; PomDoctor Ltd. Climbs 74%
Rosen Law Firm Flags April 7 Lead Plaintiff Deadline in PomDoctor Securities Class Action
Reuters  ·  03-04
Rosen Law Firm Flags April 7 Lead Plaintiff Deadline in PomDoctor Securities Class Action
Class Action Lawsuit Targets PomDoctor Ltd. Over Alleged Securities Fraud
Reuters  ·  03-04
Class Action Lawsuit Targets PomDoctor Ltd. Over Alleged Securities Fraud
Rosen Law Firm Urges PomDoctor Investors to Seek Counsel Ahead of April 7 Lead Plaintiff Deadline
Reuters  ·  02-26
Rosen Law Firm Urges PomDoctor Investors to Seek Counsel Ahead of April 7 Lead Plaintiff Deadline
Pomdoctor Investors Face April 13 Lead Plaintiff Deadline in Securities Class Action
Reuters  ·  02-24
Pomdoctor Investors Face April 13 Lead Plaintiff Deadline in Securities Class Action
Rosen Law Firm Alerts PomDoctor Investors to April 7 Lead Plaintiff Deadline in Securities Class Action
Reuters  ·  02-23
Rosen Law Firm Alerts PomDoctor Investors to April 7 Lead Plaintiff Deadline in Securities Class Action
Rosen Law Firm Urges PomDoctor Investors to Act Before April 7 Lead Plaintiff Deadline
Reuters  ·  02-20
Rosen Law Firm Urges PomDoctor Investors to Act Before April 7 Lead Plaintiff Deadline
Rosen Law Firm Urges PomDoctor Investors to Join Securities Class Action by April 7 Deadline
Reuters  ·  02-19
Rosen Law Firm Urges PomDoctor Investors to Join Securities Class Action by April 7 Deadline
Pomdoctor Ltd. Faces Shareholder Class Action Over Alleged Stock Fraud
Reuters  ·  02-17
Pomdoctor Ltd. Faces Shareholder Class Action Over Alleged Stock Fraud
Pomdoctor Limited Announces Receipt of Nasdaq Notice
THOMSON REUTERS  ·  02-02
Pomdoctor Limited Announces Receipt of Nasdaq Notice
Press Release: POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies
Dow Jones  ·  01-16
Press Release: POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies
Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative
Simply Wall St.  ·  2025-12-05
Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative
Pomdoctor H1 EPS $(1.60), Sales $24.400M
Benzinga  ·  2025-12-04
Pomdoctor H1 EPS $(1.60), Sales $24.400M

Introduction

Company Name.
PomDoctor
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--